GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Interest and Commission Paid

Exicure (STU:2H0A) Interest and Commission Paid


View and export this data going back to 2021. Start your Free Trial

What is Exicure Interest and Commission Paid?

Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Exicure (STU:2H0A) Business Description

Industry
Traded in Other Exchanges
Address
2430 N. Halsted Street, Suite 410, Chicago, IL, USA, 60614
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.